Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors
AbstractTuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) has become a frequently deadly infection due to increasing antimicrobial resistance. This serious issue has driven efforts worldwide to discover new drugs effective against Mtb. One research area is the synthesis and evaluation of pyrazinamide derivatives as potential anti-TB drugs. In this paper we report the synthesis and biological evaluations of a series of ureidopyrazines. Compounds were synthesized by reacting alkyl/aryl isocyanates with aminopyrazine or with propyl 5-aminopyrazine-2-carboxylate. Reactions were performed in pressurized vials using a CEM Discover microwave reactor with a focused field. Purity and chemical structures of products were assessed, and the final compounds were tested in vitro for their antimycobacterial, antibacterial, and antifungal activities. Propyl 5-(3-phenylureido)pyrazine-2-carboxylate (compound 4, MICMtb = 1.56 μg/mL, 5.19 μM) and propyl 5-(3-(4-methoxyphenyl)ureido)pyrazine-2-carboxylate (compound 6, MICMtb = 6.25 μg/mL, 18.91 μM) had high antimycobacterial activity against Mtb H37Rv with no in vitro cytotoxicity on HepG2 cell line. Therefore 4 and 6 are suitable for further structural modifications that might improve their biological activity and physicochemical properties. Based on the structural similarity to 1-(2-chloropyridin-4-yl)-3-phenylurea, a known plant growth regulator, two selected compounds were evaluated for similar activity as abiotic elicitors. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 789 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Bouz, G.; Juhás, M.; Niklová, P.; Janďourek, O.; Paterová, P.; Janoušek, J.; Tůmová, L.; Kovalíková, Z.; Kastner, P.; Doležal, M.; Zitko, J. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors. Molecules 2017, 22, 1797.
Bouz G, Juhás M, Niklová P, Janďourek O, Paterová P, Janoušek J, Tůmová L, Kovalíková Z, Kastner P, Doležal M, Zitko J. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors. Molecules. 2017; 22(10):1797.Chicago/Turabian Style
Bouz, Ghada; Juhás, Martin; Niklová, Pavlína; Janďourek, Ondřej; Paterová, Pavla; Janoušek, Jiří; Tůmová, Lenka; Kovalíková, Zuzana; Kastner, Petr; Doležal, Martin; Zitko, Jan. 2017. "Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors." Molecules 22, no. 10: 1797.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.